This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Synergistic antitumor activities of docetaxel and octreotide associated with apoptotic-upregulation in castration-resistant prostate cancer
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProstate Cancer Treatment and Research · Cancer, Stress, Anesthesia, and Immune Response · Radiopharmaceutical Chemistry and Applications
After this article [1] was published, concerns were raised about Figs 1, 4, 5, S4 and S5.
Specifically:
The authors did not respond to editorial follow-up on these concerns.
In the absence of the original data underlying the figures of concern, the above concerns remain unresolved and the PLOS One Editors retract this article.
All authors either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.